Engineering Antimicrobial Nanostructures to Combat Urban Drug-Resistant Biofilms: A Microbiology-Chemistry Approach with Public Health Implications
International Journal of Drug Delivery Technology · 02.06.2026 · 16 (44s)
DOI: 10.25258/ijddt.16.44s.29 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 02.06.2026. Verfasst von Sangeeta Bhogal und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Biofilms at the interface of healthcare systems, wastewater networks, densely populated built environments, and contaminated community surfaces are increasingly influencing urban antimicrobial resistance. These organized microbial communities shield pathogens against antibiotics, disinfectants, host defenses, and environmental stress, and are significant contributors to persistence, recurrence and further transmission. This review explores the ways in which antimicrobial nanostructures can be designed as drug-delivery and anti-biofilm systems to deal with resistant biofilms in urban environments. A microbiology-chemistry paradigm is highlighted: microbiology characterizes the target phenotype, ecological niche, and predominant resistance mechanisms, and chemistry and materials engineering characterize particle size, surface charge, ligand density, catalytic activity, payload release, and biocompatibility. We present the key types of nanostructures that are currently relevant to biofilm control, such as metal and metal oxide nanoparticles, polymeric and chitosan-based carriers, lipid-based systems, nitric oxide-releasing platforms, nanozymes, photodynamic systems, and metal-organic-framework hybrids. In these classes, successful designs are reduced to a few functional needs: matrix penetration, localized high drug concentration, membrane disruption, catalytic production of reactive species, and programmable or stimulus-responsive release. Translational opportunities in wound care, implant coating, catheter protection, hospital drainage systems, and urban wastewater-related surveillance are also assessed in the article, and the unresolved issues of toxicity, environmental release, manufacturing reproducibility, and regulatory standardization are mentioned. We suggest that the future generation of anti-biofilm nanostructures must be safe-by-design, context-specific, and tested in clinically and environmentally realistic systems and not just simplified mono-species assays. This combined viewpoint makes antimicrobial nanotechnology consistent with biomedical engineering and with the priorities of the public-health.
Zitieren
APA
Bhogal, S., Gupta, H. N., Kandwal, P., Tiwari, S., G, E., & Adhikari, O. (2026). Engineering Antimicrobial Nanostructures to Combat Urban Drug-Resistant Biofilms: A Microbiology-Chemistry Approach with Public Health Implications. International Journal of Drug Delivery Technology, 16(44s). https://doi.org/10.25258/ijddt.16.44s.29
Vancouver
Bhogal S, Gupta HN, Kandwal P, Tiwari S, G E, Adhikari O. Engineering Antimicrobial Nanostructures to Combat Urban Drug-Resistant Biofilms: A Microbiology-Chemistry Approach with Public Health Implications. International Journal of Drug Delivery Technology. 2026;16(44s). doi:10.25258/ijddt.16.44s.29
BibTeX
@article{Bhogal2026,
author = {Bhogal, Sangeeta and Gupta, Hrishikesh N and Kandwal, Priya and Tiwari, Shivam and G, Ezhil. and Adhikari, Omkar},
title = {Engineering Antimicrobial Nanostructures to Combat Urban Drug-Resistant Biofilms: A Microbiology-Chemistry Approach with Public Health Implications},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {44s},
doi = {10.25258/ijddt.16.44s.29}
}
EUVIMED